https://www.selleckchem.com/pr....oducts/actinomycin-d
STRATION Brazilian Registry of Clinical Trials (ReBEC) ID RBR-9rf33n, date of registration 17 May 2018.BACKGROUND Primary dysmenorrhoea (PDM) is defined as a series of pain-dominated symptoms during and after menstruation without organic lesions. Nonsteroidal anti-inflammatory drugs and oral contraceptives are usually recommended as first-line therapy for the clinical treatment of PDM, but their widespread long-term application is controversial. Radial extracorporeal shock wave therapy (rESWT) has been widely applied in musculoske
Like
Comment
Share
